nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—CA6—saliva—conduct disorder	0.268	0.797	CbGeAlD
Sulpiride—DRD3—Dopamine receptors—DRD4—conduct disorder	0.075	0.132	CbGpPWpGaD
Sulpiride—DRD2—Dopamine receptors—DRD4—conduct disorder	0.0574	0.101	CbGpPWpGaD
Sulpiride—Remoxipride—DRD4—conduct disorder	0.0497	0.525	CrCbGaD
Sulpiride—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0403	0.0708	CbGpPWpGaD
Sulpiride—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.04	0.0703	CbGpPWpGaD
Sulpiride—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—conduct disorder	0.0281	0.0493	CbGpPWpGaD
Sulpiride—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0238	0.0418	CbGpPWpGaD
Sulpiride—Remoxipride—HTR2A—conduct disorder	0.0229	0.242	CrCbGaD
Sulpiride—DRD3—brain—conduct disorder	0.0228	0.0678	CbGeAlD
Sulpiride—Amisulpride—HTR2A—conduct disorder	0.022	0.232	CrCbGaD
Sulpiride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0182	0.032	CbGpPWpGaD
Sulpiride—CA12—brain—conduct disorder	0.0178	0.0529	CbGeAlD
Sulpiride—DRD3—Monoamine GPCRs—DRD4—conduct disorder	0.0166	0.0291	CbGpPWpGaD
Sulpiride—DRD3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0139	0.0245	CbGpPWpGaD
Sulpiride—BCHE—Peptide hormone metabolism—CGA—conduct disorder	0.0135	0.0237	CbGpPWpGaD
Sulpiride—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.013	0.0228	CbGpPWpGaD
Sulpiride—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.0127	0.0223	CbGpPWpGaD
Sulpiride—CA9—Cellular response to hypoxia—EP300—conduct disorder	0.0124	0.0218	CbGpPWpGaD
Sulpiride—DRD3—Monoamine GPCRs—HTR2A—conduct disorder	0.0108	0.019	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0107	0.0187	CbGpPWpGaD
Sulpiride—DRD2—brain—conduct disorder	0.00964	0.0287	CbGeAlD
Sulpiride—CA2—brain—conduct disorder	0.00913	0.0272	CbGeAlD
Sulpiride—DRD3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0091	0.016	CbGpPWpGaD
Sulpiride—BCHE—brain—conduct disorder	0.00875	0.026	CbGeAlD
Sulpiride—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.00828	0.0145	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Other—DRD4—conduct disorder	0.00737	0.0129	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00696	0.0122	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00638	0.0112	CbGpPWpGaD
Sulpiride—CA9—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00571	0.01	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0049	0.0086	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—GABRA2—conduct disorder	0.00489	0.00858	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Other—HTR2A—conduct disorder	0.00481	0.00844	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CGA—conduct disorder	0.0042	0.00738	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—SLC6A4—conduct disorder	0.00416	0.0073	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—DRD4—conduct disorder	0.00391	0.00686	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00375	0.00658	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—CGA—conduct disorder	0.00373	0.00655	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CGA—conduct disorder	0.00364	0.00639	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—DRD4—conduct disorder	0.00345	0.00606	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0032	0.00562	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00318	0.00558	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00307	0.00539	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00305	0.00535	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.00299	0.00525	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00295	0.00517	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CGA—conduct disorder	0.00285	0.00501	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CGA—conduct disorder	0.00278	0.00488	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00274	0.00481	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00264	0.00463	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—CGA—conduct disorder	0.00255	0.00447	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00245	0.0043	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—COMT—conduct disorder	0.00235	0.00413	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CGA—conduct disorder	0.00234	0.00411	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—MAOA—conduct disorder	0.00234	0.0041	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.00211	0.0037	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0021	0.00368	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00209	0.00367	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.00209	0.00367	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CGA—conduct disorder	0.00191	0.00336	CbGpPWpGaD
Sulpiride—CA6—Metabolism—COMT—conduct disorder	0.0019	0.00333	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MAOA—conduct disorder	0.00188	0.00331	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—EP300—conduct disorder	0.00188	0.00331	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00179	0.00314	CbGpPWpGaD
Sulpiride—CA12—Metabolism—COMT—conduct disorder	0.00164	0.00288	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MAOA—conduct disorder	0.00163	0.00286	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.00161	0.00283	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0016	0.00281	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.0016	0.00281	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CGA—conduct disorder	0.00146	0.00257	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00137	0.0024	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR2A—conduct disorder	0.00136	0.00239	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—EP300—conduct disorder	0.00135	0.00237	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CGA—conduct disorder	0.00131	0.0023	CbGpPWpGaD
Sulpiride—CA2—Metabolism—COMT—conduct disorder	0.00126	0.0022	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MAOA—conduct disorder	0.00125	0.00219	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD4—conduct disorder	0.00118	0.00207	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CGA—conduct disorder	0.00113	0.00198	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD4—conduct disorder	0.00107	0.00188	CbGpPWpGaD
Sulpiride—CA9—Metabolism—COMT—conduct disorder	0.00106	0.00186	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MAOA—conduct disorder	0.00105	0.00184	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.00104	0.00183	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.00103	0.00182	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—WASF1—conduct disorder	0.000906	0.00159	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000903	0.00159	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CGA—conduct disorder	0.000865	0.00152	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD4—conduct disorder	0.00082	0.00144	CbGpPWpGaD
Sulpiride—CA6—Metabolism—EP300—conduct disorder	0.000814	0.00143	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	0.00077	0.00135	CbGpPWpGaD
Sulpiride—CA12—Metabolism—EP300—conduct disorder	0.000704	0.00124	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR2A—conduct disorder	0.000699	0.00123	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—WASF1—conduct disorder	0.000693	0.00122	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD4—conduct disorder	0.000633	0.00111	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—COMT—conduct disorder	0.000592	0.00104	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	0.000589	0.00103	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MAOA—conduct disorder	0.000588	0.00103	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00057	0.001	CbGpPWpGaD
Sulpiride—CA2—Metabolism—EP300—conduct disorder	0.000538	0.000945	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR2A—conduct disorder	0.000535	0.000939	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD4—conduct disorder	0.000484	0.000851	CbGpPWpGaD
Sulpiride—CA9—Metabolism—EP300—conduct disorder	0.000454	0.000797	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR2A—conduct disorder	0.000413	0.000725	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR2A—conduct disorder	0.000316	0.000555	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—EP300—conduct disorder	0.000254	0.000446	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EP300—conduct disorder	0.000219	0.000384	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EP300—conduct disorder	0.000167	0.000294	CbGpPWpGaD
